GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
OREXIGEN THERAPEUTIC (OREX) [hlAlert]

Orexigen Therapeutics, Inc. (Orexigen) is a biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of obesity. The combination product
candidates targeted for obesity are Contrave, which is in Phase III clinical trials, and Empatic, which is in the later stages of Phase II clinical development. Contrave is a fixed dose combination of naltrexone SR and bupropion SR. Empatic is a fixed dose combination of zonisamide SR and bupropion SR.
.
( Total: 16 Current Stock Recommendations )
OREXIGEN THERAPEUTIC   (16)
Sell Hold Buy 75%
Related companies
China Biologic ...   (4)
Buy 100%
ATHERSYS INC   (7)
Buy 100%
ACURA PHARMACEUTICAL   (2)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
Derma Sciences, Inc.   (2)
Buy 100%
Tenax Therapeutics ...   (2)
Buy 100%
ARCA BIOPHARMA INC.   (1)
Buy 100%
PROLOR Biotech, Inc.   (5)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Nutraceutical ...   (1)
Buy 100%
Show  

Date (ET)MemberRatingYTD
Gains
 
10/3/2013  
Buy
  
1/10/2014  
Buy
  
12/11/2015  
Sell
  
2/1/2011  
Hold
  
12/4/2015  
Hold
  
3/13/2009  
Buy
  
7/16/2012  
Buy
  
12/3/2010  
Sell
  
4/3/2008  
Buy
  
2/4/2008  
Buy
  
2/6/2008  
Buy
  
1/3/2008  
Buy
  
1/4/2013  
Buy
  
9/21/2011  
Buy
  
2/2/2010  
Buy
  
9/6/2012  
Buy
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy